pteridines has been researched along with Mastocytosis, Systemic in 1 studies
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peter, B | 1 |
| Gleixner, KV | 1 |
| Cerny-Reiterer, S | 1 |
| Herrmann, H | 1 |
| Winter, V | 1 |
| Hadzijusufovic, E | 1 |
| Ferenc, V | 1 |
| Schuch, K | 1 |
| Mirkina, I | 1 |
| Horny, HP | 1 |
| Pickl, WF | 1 |
| Müllauer, L | 1 |
| Willmann, M | 1 |
| Valent, P | 1 |
1 other study available for pteridines and Mastocytosis, Systemic
| Article | Year |
|---|---|
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.
Topics: Animals; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Resp | 2011 |